Showing 1 - 2 of 2
expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low. -- longevity … ; pharmaceutical ; innovation ; drugs ; Sweden …
Persistent link: https://www.econbiz.de/10009571756
The number of drugs approved by the FDA for treating cancer has increased substantially during the last 40 years. Moreover, cancer drug innovation has been accelerating: more than 8 times as many new cancer drugs were approved during 2005-2015 as were approved during 1975-1985 (66 vs. 8). During...
Persistent link: https://www.econbiz.de/10011735934